D-383-2014 Class II Terminated

Recalled by Sandoz Incorporated — Broomfield, CO

FDA drug recall D-383-2014 was initiated by Sandoz Incorporated on Oct 22, 2013 and is designated Class II. Reason for recall: Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin The recall status is terminated (terminated Jul 10, 2014). Affected quantity: 12,521 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 1, 2014
Initiation Date
Oct 22, 2013
Termination Date
Jul 10, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,521 bottles

Product description

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

Reason for recall

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

Distribution pattern

Nationwide

Code information

Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-383-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-383-2014. Report a data issue: hello@regdatalab.com.